Biocorp Production SA
PAR:ALCOR
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| FR |
|
Biocorp Production SA
PAR:ALCOR
|
154.4m EUR |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
200.1B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
174.7B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
146.9B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
126.6B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.4B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46.9B EUR |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
52.7B USD |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
49.9B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48B USD |
Loading...
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.3B USD |
Loading...
|
Market Distribution
| Min | -1 220.2% |
| 30th Percentile | 34% |
| Median | 53.6% |
| 70th Percentile | 70.2% |
| Max | 509.6% |
Other Profitability Ratios
Biocorp Production SA
Glance View
BIOCORP Production SA is a technology-driven manufacturing medical company. The company is headquartered in Issoire, Auvergne-Rhone-Alpes and currently employs 74 full-time employees. The company went IPO on 2015-07-10.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
Over the last 3 years, Biocorp Production SA’s Gross Margin has decreased from 101.8% to 91.2%. During this period, it reached a low of 90.5% on Dec 31, 2020 and a high of 101.8% on Dec 31, 2019.